-+ 0.00%
-+ 0.00%
-+ 0.00%

CRISPR Therapeutics Grants CFO Andrew Jacob Silver 25,000 Restricted Stock Units

PUBT·10/21/2026 21:42:36
Listen to the news
CRISPR Therapeutics Grants CFO Andrew Jacob Silver 25,000 Restricted Stock Units
  • CRISPR Therapeutics granted Chief Financial Officer Andrew Jacob Silver 25,000 restricted stock units on October 19, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CRISPR Therapeutics AG published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-428010), on October 21, 2026, and is solely responsible for the information contained therein.